MedPath

TTPHIL ALL TILT, a new effective dental implant placement technique, for replacing teeth in patients with missing teeth

Not yet recruiting
Conditions
Atrophy of edentulous alveolar ridge, (2) ICD-10 Condition: K081||Complete loss of teeth,
Registration Number
CTRI/2024/10/075449
Lead Sponsor
Dr Venkat Ratna Nag P
Brief Summary

Abstract:

The scope of full mouth rehabilitation using implants have increased considerably as edentulism is prevalent in about 10 percent of world population. Increase in chewing surfaces along with elimination of cantilever for the long term functional and bio-mechanical success, irrespective of the bone type is significant from patient’s and clinician’s viewpoint. There is no single technique which can be used in all types of bone. thus TTPHIL- ALL-TILT treatment protocol attempts to fill that gap.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria
  • All cases of complete edentulism, even in resorbed maxilla and mandible.
  • For the mandible, residual ridge crest of at least 4 mm width buccolingually and greater than 8 mm height; for the maxilla, residual ridge crest with enough width to insert a 3.5 mm–diameter implant, and greater than 8 mm height will be included in the study.
  • Immediate and delayed loading cases 3.
  • Patients, in whom grafting procedures or zygomatic implants would be morbid or medical conditions wherein such invasive surgical procedures are contraindicated can undergo TTPHIL-ALL TILT® protocol.
Exclusion Criteria
  • Severely debilitating systemic disease.
  • Patients undergoing chemotherapy and radiotherapy.
  • Restricted mouth opening of the patient such that access of posterior regions of maxillary and mandibular arches are compromised.
  • Evaluation appointments will be performed at 6 months; 1 year; and 2 years for assessing implant survival.
  • The primary outcome measure was implant and prosthesis survival based on function up to 2 years.
  • The secondary outcome measures included marginal bone level evaluation and the incidence of biological and esthetic complications up to 2 years of function.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
An implant will be considered successful (100% survival rate) if fulfilled function of supporting full-arch restoration, stable when tested clinically, no radiolucency on radiographs, and no peri-implant inflammation or suppuration. Therefore, the implant survival rate will be determined based on Malo’s criteria. Prosthetic success: A prosthesis was considered a failure if function was compromised for any reason. Fracture of the implant or any prosthetic component will be recorded, as will be technical complications with the abutments or other prosthetic components up to 2 years of function.10 days; 2, 4,and 6 months; 1 year; and every 6 months
Secondary Outcome Measures
NameTimeMethod
The secondary outcome measures included marginal bone level evaluation and soft tissue assessment at 6 months, 1 and 2 years of function.Biological complications: Peri-implantitis, peri-implant mucositis, fistula, bleeding on probing, suppuration, and numbness of the lower lip or chin will be evaluated.

Trial Locations

Locations (1)

Institute for Dental Implantology

🇮🇳

Hyderabad, TELANGANA, India

Institute for Dental Implantology
🇮🇳Hyderabad, TELANGANA, India
Dr Venkat Ratna Nag P
Principal investigator
9963511139
venkatratnanag@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.